ClinicalTrials.Veeva

Menu

Prevalence of Sub-Clinical Atrial Fibrillation in Elderly Patients With Hypertension, Detected Using an External Loop Recorder (ASSERT-III)

Population Health Research Institute (PHRI) logo

Population Health Research Institute (PHRI)

Status

Completed

Conditions

Hypertension
Risk Factors for Atrial Fibrillation
Elderly

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02401854
ASSERT-III

Details and patient eligibility

About

The ASSERT-III study aims to determine the incidence of sub-clinical (silent) atrial fibrillation (AF) among elderly patients with hypertension and at least one other risk factor for AF. This will be accomplished by monitoring with a wireless external loop monitor for 30 to 60 days.

Enrollment

129 patients

Sex

All

Ages

80+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients will be eligible for inclusion if they meet all of the following:

  1. Age ≥ 80 years

  2. History of hypertension OR a blood pressure of ≥ 140/90 mmHg

  3. Attending a primary care clinic, OR ambulatory resident of a chronic care facility

  4. At least one of the following additional risk factors for developing AF:

    1. Diabetes
    2. Body mass index ≥ 30
    3. History of smoking
    4. Documented Obstructive sleep apnea
    5. Cardiovascular disease
    6. Heart Failure
    7. Left ventricular hypertrophy (on ECG or echocardiography)
  5. Provide written informed consent

Exclusion criteria

  1. ECG documented history of AF or atrial flutter, with an episode duration ≥ 6 minutes

  2. Existing implanted pacemaker or defibrillator

  3. Patients considered by the investigator to be unsuitable for study follow-up because the patient:

    1. is unreliable concerning the requirements for follow-up during the study and/or compliance with the use of the external loop recorder
    2. has a life expectancy less that the expected study duration due to concomitant disease
    3. has a condition which in the opinion of the investigator, would not allow current chronic treatment with anticoagultion -

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems